These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 30278146)

  • 1. Restrictions on drugs with medical value: Moving beyond stalemate.
    Freeman TP; Mehta MA; Neill JC; Nutt DJ; Tunbridge EM; Young AH
    J Psychopharmacol; 2018 Oct; 32(10):1053-1055. PubMed ID: 30278146
    [No Abstract]   [Full Text] [Related]  

  • 2. Novel psychoactive substances: the rising wave of 'legal highs'.
    Gilani F
    Br J Gen Pract; 2016 Jan; 66(642):8-9. PubMed ID: 26719457
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of psychoactive drugs by the primary care physician. General principles].
    Nuñez-López JA
    Bol Asoc Med P R; 1983 Jun; 75(6):284-7. PubMed ID: 6577877
    [No Abstract]   [Full Text] [Related]  

  • 4. Abuse of New Psychoactive Substances: Threats and Solutions.
    Baumann MH; Volkow ND
    Neuropsychopharmacology; 2016 Feb; 41(3):663-5. PubMed ID: 26303285
    [No Abstract]   [Full Text] [Related]  

  • 5. India's National Narcotic Drugs and Psychotropic Substances policy, 2012: a 20th century document in the 21st century.
    Ambekar A; Rao R; Agrawal A
    Int J Drug Policy; 2013 Jul; 24(4):374-5. PubMed ID: 23380179
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of legal bans on poison control center contacts regarding 'legal highs'.
    Loeffler G; Craig C
    Addiction; 2013 Jul; 108(7):1348-9. PubMed ID: 23617711
    [No Abstract]   [Full Text] [Related]  

  • 7. Prospects for a public health perspective on psychoactive drug use.
    Des Jarlais DC
    Am J Public Health; 2000 Mar; 90(3):335-7. PubMed ID: 10705847
    [No Abstract]   [Full Text] [Related]  

  • 8. To prohibit or regulate psychoactive substances: has New Zealand got the right approach?
    Rizwan SB; Vernall AJ
    BMJ; 2017 Mar; 356():j1195. PubMed ID: 28314708
    [No Abstract]   [Full Text] [Related]  

  • 9. Politics and science in classifying the dangers of drugs.
    Room R; Lubman DI
    Evid Based Ment Health; 2010 Nov; 13(4):97-9. PubMed ID: 21036961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New drug law: The missing link in substance use and its control?
    Ming LC; Lee KS
    Res Social Adm Pharm; 2016; 12(6):1035-1037. PubMed ID: 27311382
    [No Abstract]   [Full Text] [Related]  

  • 11. [Psychotropic drugs].
    Sueur C
    Soins; 1991 Feb; (545):23-34. PubMed ID: 2024189
    [No Abstract]   [Full Text] [Related]  

  • 12. Dependence on psychotropic drugs: an overview.
    Edwards JG; Cantopher T; Olivieri S
    Postgrad Med J; 1984; 60 Suppl 2():29-40. PubMed ID: 6463009
    [No Abstract]   [Full Text] [Related]  

  • 13. Appraisal of the narcotic drugs and psychotropic substances (amendment) act, 2014.
    Mohapatra S; Rath N
    Asian J Psychiatr; 2015 Apr; 14():80-1. PubMed ID: 25838083
    [No Abstract]   [Full Text] [Related]  

  • 14. "So prohibition can work?" Changes in use of novel psychoactive substances among adolescents attending a drug and alcohol treatment service following a legislative ban.
    Smyth BP; James P; Cullen W; Darker C
    Int J Drug Policy; 2015 Sep; 26(9):887-9. PubMed ID: 26139009
    [No Abstract]   [Full Text] [Related]  

  • 15. Understanding the UK Psychoactive Substances Act.
    Hill RG
    Br J Clin Pharmacol; 2020 Mar; 86(3):499-504. PubMed ID: 31749206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BMA urges caution over MPs' request to collect data on patients addicted to prescription drugs.
    O'Dowd A
    BMJ; 2013 Dec; 347():f7649. PubMed ID: 24361721
    [No Abstract]   [Full Text] [Related]  

  • 17. New psychoactive substances: a public health issue.
    Guirguis A
    Int J Pharm Pract; 2017 Oct; 25(5):323-325. PubMed ID: 28895252
    [No Abstract]   [Full Text] [Related]  

  • 18. Prescribing psychoactive drugs to addicts.
    Bewley TH
    Br Med J; 1980 Aug; 281(6238):497-8. PubMed ID: 7427339
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of legislation on NPS markets in Germany - The rise and fall of 5F-ADB.
    Halter S; Haschimi B; Mogler L; Auwärter V
    Drug Test Anal; 2020 Jun; 12(6):853-856. PubMed ID: 32115831
    [No Abstract]   [Full Text] [Related]  

  • 20. [Psychotropic drugs and danger of mania].
    Klitz RR
    Med Monatsschr Pharm; 1978 Oct; 1(10):302-8. PubMed ID: 756957
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.